Cardiac Dimensions, Inc.

Heart failure is a progressive disease. It’s an expensive disease. It’s a devastating disease. Over 20% of heart failure patients with FMR die within the first year of diagnosis and 50% die within five years.1 Each year thousands of these patients find the disease has advanced and their options extremely limited. Cardiac Dimensions’ mission is to give new hope to those suffering from heart failure so they can live longer, higher quality lives. We’re harnessing our science, technology, and talent to take on this global crisis and improve the survivability for heart failure patients with FMR. Our goal is to treat patients earlier in the disease process—when it’s needed. And by uniquely treating the underlying causes—not just symptoms. We are a privately held company headquartered in Kirkland, Washington with operations in the United States, Australia, and Germany.